The market for new company creation in the biopharma sector remains healthy and poised to continue fostering the establishment of start-ups, based on a new In Vivo study of the strong initial investments that pharma and biotech companies receive.

Corza Medical, a private equity-backed surgical technologies company, has acquired Barron Precision Instruments to expand its ophthalmology surgery business and manufacturing capacity. Earlier in the year, Corza bought Katena Products, a developer of ophthalmic instruments for surgical and in-office applications.

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.

Croma Pharma is a drug and device manufacturing company in its own right, but the firm now offers regulatory consultancy services in the medical device and combination products area to small companies. What does it take?